Abstract:
The present invention relates to a composition comprising Notoginseng radix extract for preventing and treating arthritis as an effective ingredient.Notoginseng radix extract of the present invention inhibits release of tumor necrosis factor-alpha (TNF-α) and is the death of activated T-cells only, so that it can be effectively used for the production of a medicine for preventing and treating arthritis and health food as well.
Abstract:
The present invention relates to furan derivatives and pharmaceutical compositions containing them to prevent and cure osteoporosis. The furan derivatives of the present invention have effect on bone proliferation with the side effect reduced, so that they can be used for bone disease.
Abstract:
An organic light emitting device having a pyrene based electron transport compound and an electron injecting and transport layer comprising the electron transport compound is provided.
Abstract:
A fractional caching method and an adaptive contents transmitting method using the same are provided. The fractional caching method includes the steps of setting up a divided location for dividing a certain object into two parts, receiving an evict request for acquiring a space in the inside of the cache, when the evict request is transmitted, dividing a plurality of objects stored in the cache into a prefix-Object located in the head of the object and a suffix-Object located in the tail of the object from the divided location, and removing only the suffix-Object of each object, wherein the divided location is set up at a size rate that a size of the prefix-Object is in inverse proportion to the number of the destination types.
Abstract:
The present invention relates to a composition comprising Notoginseng radix extract for preventing and treating arthritis as an effective ingredient. Notoginseng radix extract of the present invention inhibits release of tumor necrosis factor-alpha (TNF-α) and is the death of activated T-cells only, so that it can be effectively used for the production of a medicine for preventing and treating arthritis and health food as well.
Abstract:
A blue fluorescent compound includes a host material being capable of transporting an electron or a hole; and a dopant material represented by following Formula 1: [Formula 1] wherein each of the R1, the R2, the R3, the R4, and the R5 is selected from hydrogen, fluorine, C1-C6 substituted or non-substituted alkyl group, C6-C30 substituted or non-substituted aromatic group, and C6-C30 substituted or non-substituted heterocyclic group, and two of the R1, the R2, the R3, the R4 and the R5 are fluorine and wherein the R6 is selected from the C6-C30 substituted or non-substituted aromatic group, and the C6-C30 substituted or non-substituted heterocyclic group.
Abstract:
A red phosphorescent compound includes a host material being capable of transporting an electron or a hole; and a dopant material represented by following Formula 1: and each of R1 to R4 is one of the group consisting of hydrogen atom (H), C1 to C6 substituted or non-substituted alkyl group, C1 to C6 substituted or non-substituted alkoxy group, and halogen atom.
Abstract:
The invention relates to a red phosphorescent compound represented by the following Formula (1) and an organic electroluminescent (EL) device using the same: wherein
Abstract:
A blue fluorescent compound includes a host material being capable of transporting an electron or a hole; and a dopant material represented by following Formula 1: wherein at least two of the R1, the R2, the R3, and the R4 are selected from substituted or non-substituted aromatic group or substituted or non-substituted heterocyclic group, and the R5 is selected from substituted or non-substituted aromatic group or substituted or non-substituted heterocyclic group.
Abstract:
A red phosphorescent compound, includes a host material being capable of transporting an electron or a hole; and a dopant material represented by following Formula 1: wherein each of R1 to R4 is selected from the group consisting of hydrogen atom (H), C1 to C6 alkyl and C1 to C6 alkoxy, and at least one of R1 to R4 is C1 to C6 alkyl, and wherein each of R5 to R7 is selected from the group consisting of hydrogen, C1 to C6 alkyl and halogen atom, and at least one of R5 to R7 is halogen atom, and wherein each of X and Y is selected from the group consisting of H, non-substituted C1 to C6 alkyl and C1 to C6 alkyl substituted by fluorine.